Arbutus Biopharma Corp. (ABUS)
5.225
+0.02
(+0.48%)
USD |
NASDAQ |
Aug 25, 13:10
Arbutus Biopharma Shareholders Equity (Quarterly) : 258.73M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 258.73M |
| March 31, 2026 | 260.18M |
| December 31, 2025 | 76.58M |
| September 30, 2025 | 77.40M |
| June 30, 2025 | 82.98M |
| March 31, 2025 | 79.16M |
| December 31, 2024 | 97.37M |
| September 30, 2024 | 106.89M |
| June 30, 2024 | 122.45M |
| March 31, 2024 | 114.64M |
| December 31, 2023 | 106.02M |
| September 30, 2023 | 119.34M |
| June 30, 2023 | 134.69M |
| March 31, 2023 | 143.92M |
| December 31, 2022 | 136.85M |
| September 30, 2022 | 145.52M |
| June 30, 2022 | 153.14M |
| March 31, 2022 | 165.84M |
| December 31, 2021 | 169.44M |
| September 30, 2021 | 130.14M |
| June 30, 2021 | 100.83M |
| March 31, 2021 | 114.15M |
| December 31, 2020 | 101.97M |
| September 30, 2020 | 97.34M |
| June 30, 2020 | 65.51M |
| Date | Value |
|---|---|
| March 31, 2020 | 73.26M |
| December 31, 2019 | 72.74M |
| September 30, 2019 | 83.64M |
| June 30, 2019 | 164.47M |
| March 31, 2019 | 181.21M |
| December 31, 2018 | 200.23M |
| September 30, 2018 | 215.27M |
| June 30, 2018 | 238.07M |
| March 31, 2018 | 232.42M |
| December 31, 2017 | 182.47M |
| September 30, 2017 | 167.39M |
| June 30, 2017 | 175.79M |
| March 31, 2017 | 189.10M |
| December 31, 2016 | 203.00M |
| September 30, 2016 | 416.62M |
| June 30, 2016 | 431.32M |
| March 31, 2016 | 538.08M |
| December 31, 2015 | 547.68M |
| September 30, 2015 | 553.81M |
| June 30, 2015 | 588.50M |
| March 31, 2015 | 593.69M |
| December 31, 2014 | 88.04M |
| September 30, 2014 | 95.50M |
| June 30, 2014 | 105.14M |
| March 31, 2014 | 105.48M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Moderna, Inc. | 6.761B |
| Insmed, Inc. | 757.49M |
| Pfizer Inc. | 85.19B |
| Gossamer Bio, Inc. | -94.03M |
| Legend Biotech Corp. | 1.230B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 274.02M |
| Total Liabilities (Quarterly) | 15.29M |
| Debt to Equity Ratio | 0.014 |
| Current Ratio | 81.42 |
| Net Debt Paydown Yield | 0.04% |